Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11263076 | Journal of Affective Disorders | 2019 | 5 Pages |
Abstract
Our data suggests levels of GRM2 are not altered in two cortical regions from subjects with mood disorders or schizophrenia. Given we have found lower levels of [3H]LY341495 binding to GRM2/3 in BA 24 from subjects with MDD, our new data argues the lower levels of radioligand binding was due to lower levels of GRM3. Our data also suggests that glutamatergic activity through GRM2 in BA 46 may differ with gender and suicide ideation.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Brian Dean, Clare Duncan, Andrew Gibbons,